Bio-Techne Stock-Based Compensation — Historical Data
Bio-Techne (TECH) stock-based compensation was $41M in FY2026 (+1% YoY). The tables below show the complete quarterly and annual stock-based compensation history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Stock-Based Compensation
Fiscal Year
Stock-Based Compensation
YoY
2026
$41M
+1%
2025
$41M
+7%
2024
$38M
-3%
2023
$39M
-15%
2022
$46M
-11%
2021
$52M
+51%
2020
$34M
+6%
2019
$32M
+14%
2018
$28M
+93%
2017
$15M
+55%
2016
$9M
+58%
2015
$6M
+69%
2014
$4M
+89%
2013
$2M
+69%
2011
$1M
+0%
2010
$1M
-27%
2009
$2M
Recent Quarterly Stock-Based Compensation
Quarter
Stock-Based Compensation
Q2 2026
$5M
Q1 2026
$10M
Q4 2025
$14M
Q3 2025
$12M
Q2 2025
$5M
Q1 2025
$11M
Q4 2024
$15M
Q3 2024
$10M
Q2 2024
$7M
Q1 2024
$8M
Q4 2023
$13M
Q3 2023
$10M
Source: TECH on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.